97 related articles for article (PubMed ID: 2013245)
21. Treatment of bone, joint, and soft-tissue infections with oral ciprofloxacin.
Greenberg RN; Kennedy DJ; Reilly PM; Luppen KL; Weinandt WJ; Bollinger MR; Aguirre F; Kodesch F; Saeed AM
Antimicrob Agents Chemother; 1987 Feb; 31(2):151-5. PubMed ID: 3566245
[TBL] [Abstract][Full Text] [Related]
22. Once-daily oral gatifloxacin versus oral levofloxacin in treatment of uncomplicated skin and soft tissue infections: double-blind, multicenter, randomized study.
Tarshis GA; Miskin BM; Jones TM; Champlin J; Wingert KJ; Breen JD; Brown MJ
Antimicrob Agents Chemother; 2001 Aug; 45(8):2358-62. PubMed ID: 11451697
[TBL] [Abstract][Full Text] [Related]
23. [A method of sequential (intravenous and oral) use of ofloxacin in the treatment of patients with infections of organs of the peritoneal cavity].
Savitskaia KI; Lobakov AI; Savov AM; Chernen'kaia TV; Nasonov VN; Rusanova EV; Silkina TA
Antibiot Khimioter; 1996; 41(9):60-7. PubMed ID: 9005790
[TBL] [Abstract][Full Text] [Related]
24. Clinical safety and efficacy of ofloxacin.
Marone P; Concia E; Grossi P; Malfitano A; Perversi L
Chemioterapia; 1988 Oct; 7(5):320-2. PubMed ID: 3224401
[TBL] [Abstract][Full Text] [Related]
25. Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections.
Ramirez-Ronda CH; Saavedra S; Rivera-Vázquez CR
Am J Med; 1987 Apr; 82(4A):220-3. PubMed ID: 3555040
[TBL] [Abstract][Full Text] [Related]
26. [Ten-year experience with the use of ofloxacin in the treatment of wound infection].
Blatun LA; Iakovlev VP; Svetukhin AM; Puchkova LS; Izotova GN
Antibiot Khimioter; 1996; 41(9):73-6. PubMed ID: 9005792
[TBL] [Abstract][Full Text] [Related]
27. [Efficacy and tolerability of intravenous ofloxacin. A French multicenter study of 273 patients].
Leroy O; Beuscart C; Sivery B; Senneville E; Mouton Y
Presse Med; 1989 Dec 16-23; 18(42):2050-4. PubMed ID: 2532345
[TBL] [Abstract][Full Text] [Related]
28. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes.
Davis SL; McKinnon PS; Hall LM; Delgado G; Rose W; Wilson RF; Rybak MJ
Pharmacotherapy; 2007 Dec; 27(12):1611-8. PubMed ID: 18041881
[TBL] [Abstract][Full Text] [Related]
29. Open-label assessment of levofloxacin for the treatment of acute bacterial sinusitis in adults.
Sydnor TA; Kopp EJ; Anthony KE; LoCoco JM; Kim SS; Fowler CL
Ann Allergy Asthma Immunol; 1998 Apr; 80(4):357-62. PubMed ID: 9564988
[TBL] [Abstract][Full Text] [Related]
30. Treatment of posttraumatic osteitis with intravenous ofloxacin.
Seibold R; Betz A
Clin Ther; 1991; 13(4):457-9. PubMed ID: 1933996
[TBL] [Abstract][Full Text] [Related]
31. Changing therapy for skin and soft tissue infections in children: have we come full circle?
Blumer JL; Lemon E; O'Horo J; Snodgrass DJ
Pediatr Infect Dis J; 1987 Jan; 6(1):117-22. PubMed ID: 3547287
[No Abstract] [Full Text] [Related]
32. Ceftriaxone in treatment of serious infections. Skin and soft tissue infections.
Gainer RB
Hosp Pract (Off Ed); 1991 Sep; 26 Suppl 5():24-30; discussion 55-7. PubMed ID: 1918219
[TBL] [Abstract][Full Text] [Related]
33. Microbiology of skin and soft tissue infections in the age of community-acquired methicillin-resistant Staphylococcus aureus.
Ray GT; Suaya JA; Baxter R
Diagn Microbiol Infect Dis; 2013 May; 76(1):24-30. PubMed ID: 23537783
[TBL] [Abstract][Full Text] [Related]
34. Effect of linezolid versus vancomycin on length of hospital stay in patients with complicated skin and soft tissue infections caused by known or suspected methicillin-resistant staphylococci: results from a randomized clinical trial.
Li JZ; Willke RJ; Rittenhouse BE; Rybak MJ
Surg Infect (Larchmt); 2003; 4(1):57-70. PubMed ID: 12744768
[TBL] [Abstract][Full Text] [Related]
35. [Levofloxacin in the field of dermatology].
Kanzaki H; Torigoe R; Yamada T; Abe Y; Shimoe K; Akiyama H; Arata J; Umemura S; Katayama H; Nishihara O
Jpn J Antibiot; 1992 May; 45(5):576-84. PubMed ID: 1512944
[TBL] [Abstract][Full Text] [Related]
36. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
[TBL] [Abstract][Full Text] [Related]
37. Cost-effectiveness comparison of sequential ofloxacin versus standard switch therapy.
Partsch DJ; Paladino JA
Ann Pharmacother; 1997 Oct; 31(10):1137-45. PubMed ID: 9337437
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of linezolid in obese patients with cellulitis.
Stein GE; Schooley SL; Peloquin CA; Kak V; Havlichek DH; Citron DM; Tyrrell KL; Goldstein EJ
Ann Pharmacother; 2005 Mar; 39(3):427-32. PubMed ID: 15701775
[TBL] [Abstract][Full Text] [Related]
39. Intravenous followed by oral ofloxacin in the treatment of community acquired lower respiratory tract infections in adults requiring hospitalisation.
Liam CK; Aziah AM; Lim KH; Wong CM
Med J Malaysia; 2000 Sep; 55(3):304-7. PubMed ID: 11200708
[TBL] [Abstract][Full Text] [Related]
40. Cefotaxime treatment of skin and skin structure infections: a multicenter study.
LeFrock JL; McCloskey RV
Clin Ther; 1982; 5 Suppl A():19-25. PubMed ID: 6293714
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
